Farther Finance Advisors, LLC Taysha Gene Therapies, Inc. Transaction History
Farther Finance Advisors, LLC
- $6.63 Trillion
- Q3 2025
A detailed history of Farther Finance Advisors, LLC transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 55 shares of TSHA stock, worth $231. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55Holding current value
$231% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TSHA
# of Institutions
165Shares Held
250MCall Options Held
463KPut Options Held
246K-
Rtw Investments, LP New York, NY24.4MShares$103 Million1.03% of portfolio
-
Ra Capital Management, L.P. Boston, MA23.6MShares$99.2 Million1.27% of portfolio
-
Avoro Capital Advisors LLC New York, NY21.7MShares$91.4 Million0.93% of portfolio
-
Morgan Stanley New York, NY19.3MShares$81.3 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY13.4MShares$56.3 Million0.01% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $204M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...